A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer

被引：0
|
作者：
Lin, Y. [1 ]
Qin, S. [2 ]
机构：
[1] Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China
[2] Peoples Liberat Army Canc Ctr, Nanjing, Jiangsu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial
    Kuo, Wen-Hung
    Yao, Chien-An
    Lin, Chih Hui
    Chang, King-Jen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [42] Treatment of partial seizures with gabapentin: Double-blind, placebo-controlled, parallel-group study
    Yamauchi, Toshio
    Kaneko, Sunao
    Yagi, Kazuichi
    Sase, Shinichi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (04) : 507 - 515
  • [43] Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
    Hui, David
    Puac, Veronica
    Shelal, Zeena
    Dev, Rony
    Hanneman, Sandra K.
    Jennings, Kristofer
    Ma, Hilary
    Urbauer, Diana L.
    Shete, Sanjay
    Fossella, Frank
    Liao, Zhongxing
    Blumenschein Jr, George
    Chang, Joe Y.
    O'Reilly, Michael
    Gandhi, Saumil J.
    Tsao, Anne
    Mahler, Donald A.
    Bruera, Eduardo
    LANCET ONCOLOGY, 2022, 23 (10): : 1321 - 1331
  • [44] Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
    Yoshifuji, Hajime
    Ishii, Tomonori
    Ohashi, Hiroki
    Yoshizawa, Katsunori
    Mihoya, Maki
    Nishikawa, Kazuko
    Nakaoka, Yoshikazu
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2025, 9 (02)
  • [45] Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial
    Maraone, Annalisa
    Trebbastoni, Alessandro
    Di Vita, Antonella
    D'Antonio, Fabrizia
    De Lena, Carlo
    Pasquini, Massimo
    JMIR RESEARCH PROTOCOLS, 2023, 12
  • [46] Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial
    Hofbauer, Lorenz C.
    Witvrouw, Richard
    Varga, Zsuzsanna
    Shiota, Naofumi
    Cremer, Malika
    Tanko, Laszlo B.
    Rooks, Daniel
    Auberson, Lixin Zhang
    Arkuszewski, Michal
    Fretault, Nathalie
    Schubert-Tennigkeit, Agnes Annette
    Papanicolaou, Dimitris A.
    Recknor, Chris
    LANCET HEALTHY LONGEVITY, 2021, 2 (05): : E263 - E274
  • [47] Temporary sympathectomy in chronic refractory angina: a randomised, double-blind, placebo-controlled trial
    Denby, Christine
    Groves, David G.
    Eleuteri, Antonio
    Tsang, Hoo Kee
    Leach, Austin
    Hammond, Clare
    Bridson, John D.
    Fisher, Michael
    Elt, Matthew
    Laflin, Robert
    Fisher, Anthony C.
    BRITISH JOURNAL OF PAIN, 2015, 9 (03) : 142 - 148
  • [48] Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase 3 DECISION trial
    Brose, M. S.
    Nutting, C.
    Jarzab, B.
    Elisei, R.
    Siena, S.
    Bastholt, L.
    de la Fourchardiere, C.
    Pacini, F.
    Paschke, R.
    Shong, Y. K.
    Sherman, S. I.
    Smit, J. W. A.
    Chung, J.
    Kappeler, C.
    Molnar, I.
    Schlumberger, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 130 - 131
  • [49] Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase 3 DECISION trial
    Paschke, R.
    Brose, M. S.
    Nutting, C.
    Jarzab, B. J.
    Elisei, R.
    Siena, S.
    Bastholt, L.
    de la Fouchardiere, C.
    Pacini, F.
    Shong, Y. K.
    Sherman, S., I
    Smit, J. W. A.
    Chung, J.
    Siedentop, H.
    Molnar, I
    Schlumberger, M.
    ONKOLOGIE, 2013, 36 : 184 - 184
  • [50] A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Extract Sceletium tortuosum (Zembrin) in Healthy Adults
    Nell, Haylene
    Siebert, Mirna
    Chellan, Pashini
    Gericke, Nigel
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2013, 19 (11) : 898 - 904
12345